ONCY

#3917
Oncolytics Biotech, Inc. Common Shares
1.06 USD
+3.92%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
1.04
1.06
Intervallo Annuale
0.33
1.51
Variazione giornaliera
+3.92%
Variazione Mensile
+7.07%
Variazione di 6 mesi
-13.11%
Variazione Annuale
+82.76%
Chiusura Precedente
1.02
Apertura
1.05
Bid
Ask
Minimo
1.04
High
1.06
Volume
42
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore Q4, 24Q4, 25 TTM

Oncolytics Biotech Inc

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Notizie